ATE321762T1 - Verfahren zur synthese von carbapenem-antibiotika - Google Patents

Verfahren zur synthese von carbapenem-antibiotika

Info

Publication number
ATE321762T1
ATE321762T1 AT99908540T AT99908540T ATE321762T1 AT E321762 T1 ATE321762 T1 AT E321762T1 AT 99908540 T AT99908540 T AT 99908540T AT 99908540 T AT99908540 T AT 99908540T AT E321762 T1 ATE321762 T1 AT E321762T1
Authority
AT
Austria
Prior art keywords
formula
synthesis
compound
heteroaryl
aryl
Prior art date
Application number
AT99908540T
Other languages
English (en)
Inventor
John M Williams
Karel M J Brands
Renato Skerlj
Peter Houghton
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810888.9A external-priority patent/GB9810888D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE321762T1 publication Critical patent/ATE321762T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99908540T 1998-03-02 1999-02-26 Verfahren zur synthese von carbapenem-antibiotika ATE321762T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7682998P 1998-03-02 1998-03-02
GBGB9810888.9A GB9810888D0 (en) 1998-05-20 1998-05-20 Process for synthesizing carbapenem antibiotics

Publications (1)

Publication Number Publication Date
ATE321762T1 true ATE321762T1 (de) 2006-04-15

Family

ID=26313717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99908540T ATE321762T1 (de) 1998-03-02 1999-02-26 Verfahren zur synthese von carbapenem-antibiotika

Country Status (8)

Country Link
EP (1) EP1060180B1 (de)
JP (1) JP3953274B2 (de)
AT (1) ATE321762T1 (de)
AU (1) AU749234B2 (de)
CA (1) CA2322658C (de)
DE (1) DE69930616T2 (de)
ES (1) ES2260900T3 (de)
WO (1) WO1999045010A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548492B1 (en) * 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
BR0112393A (pt) 2000-06-21 2003-07-08 Internat Health Man Associates Composições e processos para aperfeiçoamento de absorção oral de agentes antimicrobiais
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
EP1426376A4 (de) * 2001-08-13 2004-12-22 Eisai Co Ltd Verfahren zur herstellung von carbapenem-antibiotika
EP1442038A4 (de) * 2001-09-26 2005-01-05 Merck & Co Inc Kristalline formen von carbapenem-antibiotika und herstellungsverfahren
NZ531174A (en) 2001-09-26 2005-09-30 Merck & Co Inc Process for reducing the levels of organic solvents in carbapenem compounds
US7538212B2 (en) * 2002-11-13 2009-05-26 Kaneka Corporation Intermediate for carbapenem compound for oral administration and process for producing the same
EP2974718A1 (de) 2005-04-29 2016-01-20 Cubist Pharmaceuticals, Inc. Therapeutische zusammensetzungen
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)-1-(4-硝基苄氧羰基)-2-[(3-烯丙氧羰基)-苯基氨基甲酰基]-吡咯烷-4-基硫醇的制备方法
EP2303225B1 (de) * 2008-06-11 2013-11-20 Ranbaxy Laboratories Limited Zusammensetzungen des Kohlenstoffdioxid Adduktes von Ertapenem und Polymorphe Formen des Mononatriumsalzes von Ertapenem
CN102558182B (zh) * 2010-12-31 2015-02-11 石药集团中奇制药技术(石家庄)有限公司 一种厄他培南钠晶型及其制备方法
CN114105988B (zh) * 2022-01-24 2022-04-29 深圳市海滨制药有限公司 一种厄他培南钠的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
TW264475B (de) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds

Also Published As

Publication number Publication date
JP2002505331A (ja) 2002-02-19
CA2322658C (en) 2005-04-12
JP3953274B2 (ja) 2007-08-08
AU749234B2 (en) 2002-06-20
EP1060180A1 (de) 2000-12-20
ES2260900T3 (es) 2006-11-01
CA2322658A1 (en) 1999-09-10
DE69930616D1 (de) 2006-05-18
EP1060180A4 (de) 2004-03-10
DE69930616T2 (de) 2006-11-23
WO1999045010A1 (en) 1999-09-10
AU2794799A (en) 1999-09-20
EP1060180B1 (de) 2006-03-29

Similar Documents

Publication Publication Date Title
ATE321762T1 (de) Verfahren zur synthese von carbapenem-antibiotika
CA1112569A (en) Methods for preparation of new penicillin esters
HRP20030566B1 (en) Improved process for carbapenem synthesis
US4222942A (en) Isolation of organic acids
KR100200242B1 (ko) 클라불란산염의 제조 방법
EP0991651A4 (de) Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
EP1460065A4 (de) Verfahren zur herstellung von cyclischen diaminverbindungen bzw. deren salzen
JP5968900B2 (ja) ロスバスタチン塩の製法
RU94046012A (ru) Способ стереоспецифического гидролиза производных пиперидиндиона, продукт гидролиза и способ получения пароксетина
DE60316459D1 (de) Verfahren zur herstellung von ceftiofur
US4325886A (en) Optical resolution of acylthiopropionic acid
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
CZ149198A3 (cs) Způsob výroby farmaceuticky přijatelné soli klavulanové kyseliny
CA2030342A1 (en) Process for producing 2-carbon-substituted carbapenem derivatives
US4847266A (en) Method for preparing 6-β-halopenicillanic acids
DK0437566T3 (da) Phenylglycin-derivater
CA2531578A1 (en) A new process for preparation of imipenem
GB1464431A (en) Indolobenzazepine derivatives and a process for the manufacture thereof
EP0569587A4 (de)
KR930021632A (ko) 벤조[b]티오펜-5-일 유도체 및 이의 제조방법
HU195485B (en) Process for producing aromatic carboxylic acid derivatives and -carboxamide derivatives
EP1346979A1 (de) Verfahren zur herstellung von n-geschützten aminoalkoholen und n-geschützen aminoepoxiden
CA2319138A1 (en) Method for producing s-alkyl(aryl)-substituted imidazol derivatives
DE60001821D1 (de) Verfahren zu trennung von ftc isomere und deren derivate
EP0882713A4 (de) Verfahren zur herstellung von halogenopyridinderivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties